←back to thread

Yann LeCun to depart Meta and launch AI startup focused on 'world models'

(www.nasdaq.com)
760 points MindBreaker2605 | 2 comments | 12 Nov 25 07:25 UTC | HN request time: 0.001s | source
Show context
mehulashah ◴[12 Nov 25 13:21 UTC] No.45899804[source]▶
Most of the folks on this topic are focused on Meta and Yann’s departure. But, I’m seeing something different.

This is the weirdest technology market that I’ve seen. Researchers are getting rewarded with VC money to try what remains a science experiment. That used to be a bad word and now that gets rewarded with billions of dollars in valuation.

replies(32): >>45899874 #>>45899875 #>>45899899 #>>45899901 #>>45900006 #>>45900079 #>>45900194 #>>45900255 #>>45900503 #>>45900521 #>>45900598 #>>45900784 #>>45900879 #>>45900974 #>>45901096 #>>45901209 #>>45901645 #>>45901914 #>>45902184 #>>45902195 #>>45902236 #>>45902357 #>>45902533 #>>45902641 #>>45902792 #>>45902972 #>>45903154 #>>45903226 #>>45903630 #>>45904085 #>>45904807 #>>45906016 #
1. cantor_S_drug ◴[12 Nov 25 13:29 UTC] No.45899874[source]▶
Because when the recipe is open and public, the product's success depends on Distribution (which has been cornered by MS, Google, Apple). This is good for the ecosystem but not sure how those particular VCs will get exits.
replies(1): >>45901176 #
2. nradov ◴[12 Nov 25 15:11 UTC] No.45901176[source]▶
Very few startup products depend on distribution by Microsoft / Google / Apple. You're really just talking about a limited set of mobile or desktop apps there. Everything else is wide open. Kailera Therapeutics isn't going to live or die based on what the tech giants do.